Dimensional Fund Advisors LP Aim Immuno Tech Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.78 - $1.27 $65,174 - $106,117	-83,557 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.67 - $1.18 $145,885 - $256,933	-217,740 Reduced 72.27%	83,557 $89,000
Q4 2021 Feb 09, 2022	SELL	$0.92 - $1.96 $63,798 - $135,918	-69,346 Reduced 18.71%	301,297 $277,000
Q3 2021 Nov 12, 2021	BUY	$1.91 - $2.17 $442,132 - $502,318	231,483 Added 166.34%	370,643 $749,000
Q2 2021 Aug 12, 2021	BUY	$1.93 - $2.39 $268,578 - $332,592	139,160 New	139,160 $299,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $10.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.